Converting Skeptics: Understanding the Fundamentals of MSC Biology
Wednesday, May 29, 2024 08:00 AM - 09:00 AM
Room 212-214
Basic and Discovery Research
Roundtable
Organized by: ISCT MSC Committee
Moderator(s)
Panelists
Key Learning Objectives
1. Understand fundamental biology of MSCs and their interactions with multiple cell types including endothelial cells, macrophages, T cells, neutrophils under homeostatic and diseased conditions.
2. How does this interaction inform and change MSC potency?
3. What read-outs can be used to predict these interactions in diseased conditions?
4. Our understanding of inflammation evolves from being one static condition to a multitude of enteties with varying composition of innate and adaptive cells. Hence, the influence of MSCs will depend on MSC interaction with the type of immune cells and their respective numbers.
Moderator(s)
- Nadir Kadri, PhD, Karolinska Institutet, Sweden
- Sowmya Viswanathan, PhD, University Health Network, Canada
Panelists
- Francesco Dazzi, MD PhD, AstraZeneca, United Kingdom
- Karen English, PhD, Maynooth University, Ireland
- Maroun Khoury, PhD, IMPACT - Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Chile
Key Learning Objectives
1. Understand fundamental biology of MSCs and their interactions with multiple cell types including endothelial cells, macrophages, T cells, neutrophils under homeostatic and diseased conditions.
2. How does this interaction inform and change MSC potency?
3. What read-outs can be used to predict these interactions in diseased conditions?
4. Our understanding of inflammation evolves from being one static condition to a multitude of enteties with varying composition of innate and adaptive cells. Hence, the influence of MSCs will depend on MSC interaction with the type of immune cells and their respective numbers.
Maroun Khoury
Executive Director
IMPACT-Center of interventional medicine for precision and advanced cellular therapy
Panelist
Executive Director
IMPACT-Center of interventional medicine for precision and advanced cellular therapy
Panelist